Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi (2020)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/qai.0000000000002497
PubMed Identifier: 32925361
Publication URI: http://europepmc.org/abstract/MED/32925361
Type: Journal Article/Review
Parent Publication: JAIDS Journal of Acquired Immune Deficiency Syndromes
Issue: 5
ISSN: 1525-4135